BUSINESS NEWS
Stem Cell Therapeutics And Medicon A/S Report Positive Preliminary Response From Danish Regulatory Agency For Proposed Phase I Clinical Trial And Sign Letter Of Intent To Initiate
Stem Cell Therapeutics Corp. and Medicon A/S of Birkerod, Denmark announced today they have signed a Letter of Intent (“LOI”) for SCT to retain Medicon to conduct SCT’s first Phase I clinical trial in the NTx(TM)-265 therapeutic program for the treatment of stroke.
Article
Immunotope Vaccine to be Evaluated in Cancer Trial
Immunotope has submitted an investigational new drug application (IND) to the FDA in collaboration with Duke University to initiate a Phase I ovarian cancer clinical trial.
Article
Firm Makes Headway in Cell Therapy
Cellerant would help fight radiation using adult stem cells, not ones taken from embryos.
Article
Wall Street Biotech Insider Gets No. 2 Job at the FDA
Only a month ago, Dr. Scott Gottlieb was a Wall Street insider, promoting hot biotech stocks to investors. Now Gottlieb holds the No. 2 job at the Food and Drug Administration (FDA), the federal agency that approves new drugs, oversees their safety and affects the fortunes of companies he once touted.
Article
Invitrogen Corporation And The Scripps Research Institute Announce Research Collaboration
Invitrogen Corporation, a provider of essential life science technologies for disease research and drug discovery, and The Scripps Research Institute today announced a research collaboration directed towards the expression and characterization of membrane proteins.
Article
MARKET REPORTS
Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy, and Immunotherapeutic approaches to Cancer.
“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information, including order forms, please see:
Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1 Vol. 2
Cell Therapy Order Form
“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:
Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form
The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.
A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents
Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents